Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
- PMID: 19088106
- DOI: 10.1093/humrep/den417
Anti-angiogenic effects of green tea catechin on an experimental endometriosis mouse model
Abstract
Background: The development of new blood vessels plays an essential role in growth and survival of endometriosis. Epigallocatechin gallate (EGCG) from green tea has powerful anti-angiogenic properties and our aim was to evaluate these properties in experimental endometriosis.
Methods and results: Eutopic endometrium from endometriosis patients was transplanted s.c. to severely compromised immunodeficient mice, randomly treated i.p. with EGCG (anti-angiogenic and -oxidant), Vitamin E (a non-angiogenic antioxidant) or saline for 2 weeks. The endometrial implant, including adjacent host outer skin and subcutaneous layers plus inner abdominal muscle and peritoneum, was collected. New microvessels were determined by species-specific immunohistochemistry. Angiogenic factors in lesions and abdominal muscle were detected by quantitative real-time PCR. Apoptosis was studied by terminal deoxynucleotidyltransferase-mediated dUTP nick-end labelling and quantitative real-time PCR. In saline control, endometrial implants developed new blood vessels with proliferating glandular epithelium and were tightly adhered to host subcutaneous and abdominal muscle layers. After EGCG, endometriotic lesions were smaller than control (P < 0.05), and glandular epithelium was smaller and eccentrically distributed. Angiogenesis in lesions from the implant and adjacent tissues was under-developed, and microvessel size and density were lower (both P < 0.01) than control. mRNA for angiogenic vascular endothelial growth factor A, but not hypoxia inducible factor 1, alpha subunit, was significantly down-regulated in lesions after EGCG (P < 0.05). In addition, apoptosis in the lesions was more obvious, and nuclear factor kappa B and mitogen activated protein kinase 1 mRNA levels were up-regulated (P < 0.05) after EGCG treatment. No differences were observed with Vitamin E treatment.
Conclusions: EGCG significantly inhibits the development of experimental endometriosis through anti-angiogenic effects.
Similar articles
-
Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.Fertil Steril. 2011 Oct;96(4):1021-8. doi: 10.1016/j.fertnstert.2011.07.008. Epub 2011 Aug 6. Fertil Steril. 2011. PMID: 21821246
-
Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.Angiogenesis. 2013 Jan;16(1):59-69. doi: 10.1007/s10456-012-9299-4. Epub 2012 Sep 5. Angiogenesis. 2013. PMID: 22948799
-
Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.Hum Reprod. 2008 Oct;23(10):2308-18. doi: 10.1093/humrep/den245. Epub 2008 Jul 4. Hum Reprod. 2008. PMID: 18603648
-
Animal models for anti-angiogenic therapy in endometriosis.J Reprod Immunol. 2013 Mar;97(1):85-94. doi: 10.1016/j.jri.2012.10.012. J Reprod Immunol. 2013. PMID: 23432875 Review.
-
The role of GnRH analogues in endometriosis-associated apoptosis and angiogenesis.Gynecol Obstet Invest. 2008;66 Suppl 1:10-8. doi: 10.1159/000148026. Epub 2008 Oct 21. Gynecol Obstet Invest. 2008. PMID: 18936547 Review.
Cited by
-
Anti-inflammatory cytokines in endometriosis.Cell Mol Life Sci. 2019 Jun;76(11):2111-2132. doi: 10.1007/s00018-019-03056-x. Epub 2019 Mar 2. Cell Mol Life Sci. 2019. PMID: 30826860 Free PMC article. Review.
-
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice.Reprod Biol Endocrinol. 2018 Apr 3;16(1):32. doi: 10.1186/s12958-018-0347-9. Reprod Biol Endocrinol. 2018. PMID: 29615065 Free PMC article.
-
Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review.Nutrients. 2021 Jul 24;13(8):2532. doi: 10.3390/nu13082532. Nutrients. 2021. PMID: 34444692 Free PMC article.
-
Common Beverage Consumption and Benign Gynecological Conditions.Beverages (Basel). 2024 Jun;10(2):33. doi: 10.3390/beverages10020033. Epub 2024 May 1. Beverages (Basel). 2024. PMID: 38948304 Free PMC article.
-
Vascular endothelial growth factor receptor-2 inhibitor cediranib causes regression of endometriotic lesions in a rat model.Int J Clin Exp Pathol. 2015 Feb 1;8(2):1165-74. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 25973002 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical